<p>The classifier rules for venetoclax containing combination drugs.</p>
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
The classifier rules for venetoclax containing combination drugs.
应用场景：
创建时间：
2026-02-23
相关数据集
A phase II trial in patients with acute promyelocytic leukaemia (APML) to evaluate the effects of: all-trans retinoic acid (ATRA) combined with intensive idarubicin during induction and consolidation; subsequent intermittent all-trans retinoic acid; and molecular monitoring for evidence of minimal residual leukaemia and for evidence of incipient relapse, as measured by remission rate, relapse rate and overall survival. (APML03)
Dataset includes: Data for 107 patients with newly diagnosed APL Treatment involved use of all-trans retinoic acid (ATRA) combined with idarubicin Demographic data Diagnostic data Treatment data Outco
Research Data Australia170
Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia. Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia
We report that Chidamide shows significant anti- proliferation and more specifically anti-NOTCH effects in both cell lines and primary cells of T-ALL patients. By analyzing the expression profile char
NIAID Data Ecosystem90
Engineered Tr1 cells designed for clinical use can eliminate primary pediatric AML blasts
Purpose: To investigate the transcriptome of primary pediatric acute myeloid leukemia to identify molecular signatures correlated with sensitivity to LV-10 mediated killingMethod: RNA sequencing of p
干细胞与再生医学数据中心2022-02-20 更新60
Dataset_Bories et al.xlsx
Minimal dataset used for the manuscript entitled "Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine", Bories et al
DataCite Commons2020-09-01 更新150
Data Set for Retrospective cohort study monitoring Pegaspargase activity in acute lymphoblastic leukemia patients with and without premedication Lossaso M, Messinger Y, Bostrom B
Data from children and young adults with acute lymphoblastic leukemia receiving pegaspargase with and without premedications given to prevent high grade allergic reactions including anaphylaxis. Date
DataCite Commons2020-09-20 更新70
